Sfoglia per Autore
Successful treatment of hepatocellular carcinoma (hcc) with transchateter arterial embolization (tae) with microspheres (embosphere)
2005 A. Nicolini, A. Sangiovanni, P. Fasani, L. Forzenigo, G.M. Prati, R. Romeo, S. Crespi, G. Ronchi, P. Biondetti, M. Colombo
Successful treatment of hepatocellular carcinoma (HCC) with transchateter arterial embolization (TAE) with microspheres (embosphere)
2006 A. Nicolini, A. Sangiovanni, P. Fasani, L. Forzenigo, S. Crespi, L. Giaramita, G.M. Prati, R. Romeo, P. Biondetti, M. Colombo
The natural history of compensated cirrhosis due to hepatitis C virus : A 17-year cohort study of 214 patients
2006 A. Sangiovanni, G.M. Prati, P. Fasani, G. Ronchi, R. Romeo, M. Manini, E. Del Ninno, A. Morabito, M. Colombo
Serum expression of lectin reactive alphafetoprotein, des-gamma-carboxy prothrombin, Golgi protein-73 antigen and antibody, for the diagnosis of hepatocellular carcinoma
2007 A. Sangiovanni, R. Romeo, G.M. Prati, A. Manini, M. Iavarone, G. Ronchi, M. Colombo
Prospective evaluation of staging systems for hepatocellular carcinoma detected during surveillance of cirrhotic patients
2007 A. Sangiovanni, M. Viganò, M. Iavarone, A. Aghemo, B. Cesana, G.M. Prati, M.A. Manini, R. Romeo, M. Colombo
Genotype dependent pattern of Peginterferon alfa-2B/Ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis : a single centre study of 471 naïve patients
2008 A. Aghemo, M. Rumi, S. Monico, G.M. Prati, G. Ronchi, M. Colombo
Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatiti sC virus infected patients with cirrhosis : a single center study of 471 naive patients
2008 A. Aghemo, M. Rumi, S. Monico, G.M. Prati, G. Ronchi, M. Colombo
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients
2008 A. Aghemo, M. Rumi, G.M. Prati, S. Monico, M.F. Donato, M. Colombo
Prevalence of psychiatric disorders during PEG – Interferon and Ribavirin therapy in patients with chronic hepatitis HCV-correlated
2009 B.M. Dell’Osso, M. Rumi, G.M. Prati, A.M. Aghemo, R. D’Ambrosio, I. Balossi, N. D’Urso, F. Castellano, M. Palazzo, M. Colombo, A.C. Altamura
Interferoni pegilati nel trattamento dei pazienti con epatite cronica HCV : esperienze a confronti
2009 M.G. Rumi, A. Aghemo, G.M. Prati, R. D’Ambrosio
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype
2009 A. Aghemo, M. Rumi, S. Monico, G.M. Prati, R. D'Ambrosio, M.F. Donato, M. Colombo
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-alpha 2a in chronic hepatitis C : an in vitro and in vivo study
2009 A. Aghemo, L. Ronzoni, M. Rumi, G.M. Prati, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegykated interferon-α2A in chronic hepatitis C : an in vitro and in vivo study
2009 G.M. Prati, A. Aghemo, L. Ronzoni, M. Rumi, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M. Cappellini, M. Colombo
The influence of liver fibrosis on the outcome of pegylated interferon and ribavirin anti-hac therapy : a sub-analysis of the mist study
2009 G.M. Prati, M. Rumi, A. Aghemo, R. D’Ambrosio, S. De Nicola, M. Colombo
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3 : Should we utilize more?
2009 A. Aghemo, M.G. Rumi, G.M. Prati, M. Colombo
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study
2009 A. Aghemo, L. Ronzoni, M.G. Rumi, G.M. Prati, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study
2009 A. Aghemo, M. Rumi, G.M. Prati, R. D’Ambrosio, S. De Nicola, M. Colombo
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study
2009 G.M. Prati, A. Aghemo, L. Ronzoni, M.G. Rumi, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo
Randomized Study of Peginterferon-alpha2a Plus Ribavirin vs Peginterferon-alpha2b Plus Ribavirin in Chronic Hepatitis C
2010 M.G. Rumi, A. Aghemo, G.M. Prati, R. D'Ambrosio, M.F. Donato, R. Soffredini, E. Del Ninno, A. Russo, M. Colombo
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy
2011 R. D'Ambrosio, A. Aghemo, M. Rumi, M. Primignani, A. Dell' Era, P. Lampertico, M. F. Donato, S. De Nicola, G. M. Prati, R. de Franchis, M. Colombo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile